The effects of temperature and scopolamine on N-methyl-D-aspartate antagonist-induced neuronal necrosis in the rat.
The effects of temperature and scopolamine on dizocilpine maleate-induced neuronal necrosis in the rat cingulate/retrosplenial cortex, entorhinal/olfactory cortices and the dentate gyrus were studied. Mild, protracted hypothermia (48 h at a brain temperature of 34 degrees C), induced by a servo-controlled "exposure technique" in the awake female rat, significantly reduced dizocilpine maleate (5.0 mg/kg, i.p.)-induced neuronal death in the cingulate/retrosplenial and entorhinal/olfactory cortices seven days following drug administration. Scopolamine (0.25 mg/kg, i.p.), putatively neuroprotective [Olney J. W. et al. (1991) Science 254, 1515-1518], did not reduce injury in the cingulate/retrosplenial cortex of female rats following one injection, but did following two and three doses. Scopolamine had no significant effect in the other brain regions. A temperature elevation of only 1 degree C above baseline for 48 h in awake female rats increased dizocilpine maleate-induced damage. Finally, the sex differences in N-methyl-D-aspartate antagonist toxicity were replicated and extended to other structures, and found not to be due to temperature differences. Our data show that dizocilpine maleate neurotoxicity is temperature sensitive. Scopolamine treatment needed to be prolonged in order to reduce injury, and even then was only efficacious in one of three brain regions. The results underscore the importance of using neuronal necrosis in several brain regions as the endpoint and for the use of prolonged therapeutic interventions. Furthermore, given the potential hypothermic action of other putative neuroprotective drugs, a mechanistic re-evaluation of N-methyl-D-aspartate antagonist-induced injury is needed, with precise brain temperature measurement.
Colbourne
F
F
Department of Pathology, Faculty of Medicine, University of Calgary, Alberta, Canada.
Rakić
D
D
Auer
R N
RN
D000818:Animals; D002540:Cerebral Cortex / Q000187:drug effects* / Q000473:pathology; D016291:Dizocilpine Maleate / Q000633:toxicity*; D018728:Entorhinal Cortex / Q000187:drug effects / Q000473:pathology; D018691:Excitatory Amino Acid Antagonists / Q000633:toxicity*; D005260:Female; D006179:Gyrus Cinguli / Q000187:drug effects / Q000473:pathology; D006358:Hot Temperature / Q000009:adverse effects*; D007036:Hypothermia, Induced; D008297:Male; D016202:N-Methylaspartate / Q000037:antagonists & inhibitors*; D009336:Necrosis; D009474:Neurons / Q000187:drug effects* / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D009833:Olfactory Pathways / Q000187:drug effects / Q000473:pathology; D051381:Rats; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000502:physiology*; D012601:Scopolamine / Q000494:pharmacology*; D012727:Sex Characteristics; D013238:Stereotaxic Techniques
D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D016202:N-Methylaspartate; D016291:Dizocilpine Maleate; D012601:Scopolamine